When was Baylor Genetics founded?

Baylor Genetics was founded in 1978 and raised its 1st funding round 48 years after it was founded.

Where is Baylor Genetics located?

Baylor Genetics is headquartered in Houston, United States.

How many employees does Baylor Genetics have?

As of Sep 30, 2026, the latest employee count at Baylor Genetics is 666.

Is Baylor Genetics a funded company?

Baylor Genetics is a funded company, having raised a total of $***** in its 1st and only funding round, a Series C round on Jul 01, 2026.

When was the latest funding round of Baylor Genetics?

Baylor Genetics' latest funding was a $***** Series C round on Jul 01, 2026, with participation from 0 investor.

Where does Baylor Genetics rank among its competitors?

Baylor Genetics ranks 66th amongst 939 active competitors, of which 138 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Baylor Genetics, which secured $50M in Jul, 2026.

Who are the top competitors of Baylor Genetics?

Baylor Genetics' top competitors include Strand Life Sciences, MedGenome and Caris Life Sciences. Among them, Baylor Genetics secured the most recent funding round in July, 2026.

Baylor Genetics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of genetic testing and molecular diagnostics services. The company is developing genetic testing and molecular diagnostics and provides clinically relevant solutions. The company offers a large collection of catalog tests, along with whole-exome sequencing and array-based genotyping for a large number of diseases.

Website: www.baylorgenetics.com/
Social

Key Metrics

Founded Year

1978

Location

Houston, United States

Stage

Series C

Total Funding

$50M in 1 round

Latest Funding Round

Series C, Jul 01, 2026, $*****

Ranked

66^th among 939 active competitors

Employee Count

666 as on Sep 30, 2026

Similar Companies

Strand Life Sciences & 1147 more

View Baylor Genetics' full profile

Baylor Genetics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BAYLOR MIRACA GENETICS LABORATORIES, LLC CIN: 472290309 , United States, Active	Dec 31, 1999	-	407 (As on Dec 31, 2024)	-

Baylor Genetics has raised a total funding of $50M over 1 round.

Here is the list of recent funding rounds of Baylor Genetics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2026	9056992	Series C	7611976	2808873	3071812	5284472

Access funding benchmarks and valuations. Sign up today!

View details of Baylor Genetics's funding rounds and investors

The founders of Baylor Genetics are Tom Caskey and Art Beaudet.

Here are the details of Baylor Genetics' key team members:

Tom Caskey: Co-Founder of Baylor Genetics.
Art Beaudet: Co-Founder of Baylor Genetics.

View details of Baylor Genetics's Founder profiles and Board Members

Baylor Genetics' employee count trend

Baylor Genetics has 666 employees as of Sep 26. Here is Baylor Genetics's employee count trend over the years:

Employee count trend for Baylor Genetics

Uncover Baylor Genetics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Baylor Genetics include Strand Life Sciences, MedGenome and Caris Life Sciences. Here is the list of Top 10 competitors of Baylor Genetics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, WestBridge Capital & 92 others	74/100
2nd	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	Novo Holdings, Peak XV Partners & 30 others	70/100
3rd	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	66/100
4th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
5th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Gilde Healthcare, Advent Life Sciences & 11 others	62/100
6th	Repare Therapeutics 2016, Montreal (Canada), Acquired	Developer of targeted therapies to address the genetic alterations associated with selected tumors	$166M	Versant Ventures, Cowen & 13 others	60/100
7th	Seres Therapeutics 2010, Cambridge (United States), Public	Developer of microbiome therapeutics to treat a wide range of diseases	$134M	Flagship Pioneering, Mayo Clinic Business Accelerator ... & 8 others	60/100
8th	Exicure 2009, Skokie (United States), Public	developer of gene silencing & immunomodulatory drugs using spherical nucleic acid (SNA) technology	$72.3M	Abbott Biotech Ventures, Luye Pharma & 18 others	60/100
9th	Exosome Diagnostics 2008, Boston (United States), Acquired	Developer of blood-based cancer molecular diagnostics for patient stratification and disease monitoring	$119M	Forbion, NGN Capital & 7 others	60/100
10th	Solid Biosciences 2014, Cambridge (United States), Public	Developer of gene therapy platform for Duchenne muscular dystrophy	$92.5M	Bain Capital Life Sciences, RA Capital Management ... & 18 others	60/100
66th	Baylor Genetics 1978, Houston (United States), Series C	Provider of genetic testing and molecular diagnostics services	$50M	-	45/100